$NCSM

Mitchell Valerie A sold (to issuer) 26,772 shares of NCSM

Mitchell Valerie A sold (to issuer) 26,772 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · Mitchell Valerie A
Published Sep 1, 2026, 1:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Neutral
medium confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMNeutralLow
01

Why it matters

Because the transaction is a sale to the issuer with no disclosed price and no 10b5-1 plan, it is more useful for monitoring insider activity than for forecasting near-term operating performance.

02

Market read

Traders may note the insider sale, but the disclosure lacks value/price details and does not provide a new fundamental catalyst.

03

What to watch

Insider sales to the issuer can be administrative (e.g., buyback participation) and may not reflect a directional view; also, holdings after the transaction show 0 shares, which can be driven by prior grants/vesting schedules rather than new bearish information.

Relevance 4/10Novelty 3/10Timing: filed 2026-09-01 (Form 4 insider transaction)

Background

The filing is an SEC Form 4 insider transaction for NCS Multistage Holdings, Inc., reported by a director.

Company-level read

Ticker impact

$NCSMNeutralMedium confidence
Context

Mitchell Valerie A, a director of NCS Multistage Holdings, sold 26,772 shares to the issuer on 2026-09-01 under Form 4.

Expected impact

Limited near-term impact; any reaction is likely noise unless paired with other disclosures.

Evidence & confidence

Form 4 shows a director sale to the issuer (buyback participation style) with price not disclosed and no 10b5-1 plan, but the transaction size and lack of price/value details reduce tradable inference.

Market effects

No clear sector read-through from a single director sale to the issuer.

None.

None.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, but the sale is to the issuer and price/value are not provided, limiting conviction.

Key entities

  • NCS Multistage Holdings, Inc.

    Subject of the Form 4 insider transaction; director sold 26,772 shares to the issuer on 2026-09-01.

  • Mitchell Valerie A

    Director who reported the sale to the issuer; holdings after transaction are 0 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles